Terra Nova Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Terra Nova Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-658	Closed	-$242K	–	81
2016 Q4	$242K	Buy	+658	New	+$250K	0.49%	61
2016 Q2	–	Sell	-1,125	Closed	-$405K	–	99
2016 Q1	$405K	Sell	1,125 -2,044	-64%	-$842K	0.47%	75
2015 Q4	$1.72M	Sell	3,169 -2,776	-47%	-$1.5M	1.91%	15
2015 Q3	$2.77M	Buy	5,945 +524	+10%	+$281K	2.45%	6
2015 Q2	$2.77M	Sell	5,421 -220	-4%	-$107K	2.27%	11
2015 Q1	$2.55M	Buy	+5,641	New	+$2.39M	2.11%	10

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Terra Nova Asset Management's REGN Position: Q1 2017 in Review

Terra Nova Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2017, closing a stake of 658 shares — an estimated $242K sold.

Terra Nova Asset Management first reported a position in REGN in Q1 2015 and held it in 6 quarters. The position peaked at $2.77M in Q3 2015. 578 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

Terra Nova Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Terra Nova Asset Management sold 658 Regeneron Pharmaceuticals shares in Q1 2017, an estimated $242K.
Terra Nova Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Terra Nova Asset Management's Regeneron Pharmaceuticals position peaked at $2.77M in Q3 2015.
578 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on Terra Nova Asset Management's 13F filing for Q1 2017, filed 3 May 2017.